-
The introduction of acellular pertussis vaccines represented an important advance in public health, but developing a vaccine is not synonymous with protecting a population.
-
The FDA has approved the first oral medication for the treatment of patients with relapsing forms of multiple sclerosis.
-
The prophylactic use of aspirin (asa) provides risk reduction when used for secondary prophylaxis.
-
The ECG above was obtained from a slender and previously healthy 27-year-old woman having atypical chest discomfort. Is there evidence of chamber enlargement?
-
Your next patient tells you she would like to use oral contraceptives (OCs) for birth control, but she says a family member told her using pills would affect her long-term fertility. What information do you provide her regarding OCs?
-
Microbicide research is moving forward with two new developments: the Food and Drug Administration (FDA) has granted Fast Track approval designation for 1% tenofovir gel, which will facilitate the development and expedite the review of the drug.
-
Results from a long-term follow-up analysis of participants in the Women's Health Initiative (WHI) suggest that among postmenopausal women, use of estrogen plus progestin is associated with an increased incidence of breast cancers that are more advanced, and with a higher risk of deaths attributable to breast cancer.
-
Question: What is the evidence that two condoms may be used at once? Who does this? What are their reasons for doing this? What are the other things that can do done to prevent condom breakage?
-
The end of September, marking six months after President Obama signed into law the Patient Protection and Affordable Care Act, was the effective date for numerous provisions intended to expand patients' rights and coverage under private insurance.
-
Add Beyaz and Lo Loestrin Fe to the list of birth control choices for U.S. women. Both oral contraceptives (OCs) received Food and Drug Administration (FDA) approval in late 2010.
